Ticker
KILITCH
Analysis
Kilitch Drugs (india) Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to KILITCH.
Kilitch Drugs (india) Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to KILITCH.
KILITCH
Stock
$67.5M
Health Technology
Pharmaceuticals: Major
INR
Kilitch Drugs (india) Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated November 14, 2025, titled "Press Release - H1FY26 Financial Results".
Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated May 22, 2025, titled "Q4FY25 Financial Results".
Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated February 12, 2025, titled "Financial Results Q3FY25".
Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated February 04, 2025, titled "Bhavin Mehta, Director appointed as vice chairman of PHARMEXCIL".
Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated February 04, 2025, titled "Bhavin Mehta, Director appointed as vice chairman of PHARMEXCIL".
Review valuation context for Kilitch Drugs (india) Limited.
Review future growth context for Kilitch Drugs (india) Limited.
Review past performance context for Kilitch Drugs (india) Limited.
Review financial health context for Kilitch Drugs (india) Limited.
Review dividend context for Kilitch Drugs (india) Limited.
Review management context for Kilitch Drugs (india) Limited.
Review ownership context for Kilitch Drugs (india) Limited.
Review other information context for Kilitch Drugs (india) Limited.
Review community context for Kilitch Drugs (india) Limited.